Technology Profiles
 Profile Detail
Molecular Diagnostics partners sought (10 GB 44O7 3HOV)
A company based in London is searching for partners to collaborate on its novel technology for high-accuracy, rapid and automated interpretation of qPCR/real-time PCR data. The firm is looking for partners in molecular diagnostics to help in the optimisation of its technology, to help with integrating it into existing thermal cyclers, and for joint R&D of new instrumentation such as point-of-care devices.
Country: United Kingdom
Type: REQUEST
Date: 21.10.2010
The company draws together experts in molecular biology, mathematics, algorithmics, computer science, programming and data analysis to provide automated, novel solutions to data analysis problems in molecular diagnostics. Its first technology (patents pending) enables rapid, automated analysis of qPCR/real-time PCR data to near-100% or even 100% sensitivity and specificity, and applies to both detection and quantification.
In addition, the technology provides near-instantaneous results and negates the need for manual interpretation and setting of user parameters, and does not require any expertise in the field to operate successfully. It is also computationally light, allowing its integration with portable devices or for high-throughput purposes.
So far the technology has been externally validated with datasets provided by two major hospitals in the UK, compared with expert manual interpretation. For swine 'flu data, automated interpretation was found to be 99.2% congruent to expert manual interpretation, while for Hepatitis B Virus, the result given was 100% congruence.
The technology has been developed as a scalable application programming interface, which allows the interpretation of very large volumes of data with increased speed and throughput, including multiplex capability, thus saving research and development resources and costs for interpretation for diagnostics. It further includes automated outlier detection, enabling the identification of samples that require re-running due to ambiguous results and therefore providing a reliable standard for qPCR/real-time PCR.
The technology has the potential to enable access to qPCR/real-time PCR where previously cost of training or lack of expertise prevented this. Thus, partnering on collaborative projects could open new and exciting commercial opportunities.
Technical Specifications / Specific technical requirements:
The company is looking for partners for the following projects:
" Optimisation of its core technology for either its performance or its usability." Further validation of its technology on very large data sets, such as epidemiological studies. " Integration of its technology with existing thermal cyclers." Co-development of new cyclers, such as point-of-care devices." Joint bids for charity, government or EU grants
Degree of development:
Patents/Rights:
Requested Cooperation: Joint further development, Testing of new applications, Adaptation to specific needs
- Type of partner sought:industry, hospital or academic institute
- Specific area of activity of the partner:diagnostic or biotech
- Task to be performed by the partner sought:testing and development
Type of Organisation:
Status: NEW
| 
